Adial PharmaceuticalsADIL
13F holders, Q1 2024 (March 31)1holders
$1.33avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Adial Pharmaceuticals Inc. (ADIL) in their 13F filings. The largest holder was Raffa Wealth Management, LLC ($3K).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Raffa Wealth Management, LLC | 0.00% | No change | 2,093 | $3K |
"% of holder's portfolio" is ADIL's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.